Kymanox Named as Winner of 2022 Triangle Business Journal Fast 50 Award

Becoming a Gemstone: Full AAV Capsid Separation and Final AAV Product

The Path from Lump of Coal to Gemstone: Challenges with AAV Purification

Improved Biomanufacturing Using Hofmeister Series Applications

Why “Off-The-Shelf” Devices Do Not Circumvent Design Controls

Gene Therapy Diamonds in the Rough: Adeno-Associated Viruses (AAVs)

Kymanox Announces Newest Addition to the Executive Advisor Team: Paul Jansen

Kymanox Announces First Kymanox Executive Advisor: Fran DeGrazio